Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria.

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care. 2014 May 05; 18(3):R90.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.